Hribernik, Nežka http://orcid.org/0000-0002-6468-9906
Huff, Daniel T http://orcid.org/0000-0001-9792-4119
Studen, Andrej http://orcid.org/0000-0002-1254-9530
Zevnik, Katarina http://orcid.org/0000-0001-5665-4837
Klaneček, Žan http://orcid.org/0000-0003-3409-7771
Emamekhoo, Hamid http://orcid.org/0000-0002-8506-8703
Škalic, Katja
Jeraj, Robert http://orcid.org/0000-0002-2192-2931
Reberšek, Martina http://orcid.org/0000-0002-7025-8571
Article History
Received: 24 September 2021
Accepted: 5 December 2021
First Online: 27 December 2021
Declarations
:
: The study was approved by the Institutional Review Board Committee of both Institutions (Approval number: 2016-0418 in Madison, USA; ERIDKE-0005/2020 in Ljubljana, Slovenia) and was conducted following the ethical standards defined by the Declaration of Helsinki.
: The study was conducted with acknowledgement and consent of the subjects. At OIL, patients have signed informed consent for treatment and consent allowing the usage of their data for scientific purposes. At the UWCCC, the study was approved with a waiver of informed consent.
: Robert Jeraj is a co-founder and CSO of AIQ Solutions, Madison, WI, USA. No potential conflicts of interest were disclosed for other co-authors.